Laboratory of Molecular OncoSignalling
THE SCOPE OF THE RESEARCH
The group is interested in cancer biology, cellular signalling during oncogenesis and the identification of novel targets for cancer therapies. The main aim of the research is to identify the molecular processes responsible for the development and progression of cancer and to use that knowledge to design novel anticancer treatments. Currently, the group focuses on investigating the oncogenic signalling activated by MLK4 in breast cancer and uncovering the importance of MLK4-dependent cross-talk signalling between tumour microenvironment and breast cancer cells.